Watchlist Price Alert

Sagimet Biosciences Inc. (SGMT)

NASDAQ: SGMT · Real-Time Price · USD

8.68

0.41 (4.96%)

At close: Jun 16, 2025, 10:12 AM

Sagimet Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q1 2022	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	64.72M	75.84M	77.01M	95.96M	176.78M	75.14M	101.84M	18.51M	12.34M	158K	-56.73M	74.94M
Short-Term Investments	79.85M	75.41M	75.47M	70.41M	16.93M	19.76M	n/a	n/a	12.92M	32.19M	113.46M	n/a
Long-Term Investments	n/a	7.41M	17.47M	22.12M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	62K	306K	n/a	n/a	n/a	n/a	n/a	n/a	27K	27K	-56.73M	27K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.5M	463K	407K	130K	108K	397K	77K	2.74M	1.42M	34K	n/a	37K
Total Current Assets	146.07M	152.77M	157.19M	166.75M	194.49M	96.65M	102.82M	21.35M	27.05M	32.79M	56.73M	77.01M
Property-Plant & Equipment	38K	77K	114K	151K	37K	73K	109K	144K	178K	212K	n/a	161K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	100K	7.79M	17.59M	22.27M	37K	73K	109K	144K	205K	239K	-56.73M	188K
Total Assets	146.17M	160.26M	174.78M	189.02M	194.53M	96.72M	102.92M	21.5M	27.25M	33.03M	n/a	77.2M
Account Payables	3.22M	1.43M	1.15M	1.99M	531K	186K	1.7M	2.72M	1.46M	1.13M	n/a	1.86M
Deferred Revenue	n/a	n/a	n/a	-153K	n/a	5.17M	3.15M	2.32M	3.52M	3.96M	n/a	767K
Short-Term Debt	39K	n/a	n/a	153K	n/a	65K	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	3.92M	5K	11K	-143K	3.64M	491K	95K	411K	1.03M	57K	n/a	1.05M
Total Current Liabilities	7.18M	4.45M	4.09M	5.73M	4.51M	5.65M	5.05M	5.29M	5.29M	5.28M	n/a	3.13M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	1K	214.63M	214.63M	214.62M	n/a	214.63M
Total Long-Term Liabilities	n/a	n/a	n/a	n/a	3.95M	n/a	1K	214.63M	214.66M	214.7M	n/a	214.66M
Total Liabilities	7.18M	4.45M	4.09M	5.73M	4.51M	5.65M	5.05M	219.91M	219.95M	219.98M	n/a	217.78M
Total Debt	39K	78K	116K	153K	26K	65K	103K	140K	176K	211K	n/a	176K
Common Stock	3K	3K	3K	3K	3K	2K	2K	1K	1K	1K	n/a	1K
Retained Earnings	-313.49M	-295.31M	-279.11M	-264.49M	-256.37M	-249.74M	-241.59M	-235.24M	-228.46M	-221.87M	n/a	-172.47M
Comprehensive Income	121K	230K	441K	-23K	7K	30K	-0.00	-214.63M	-13K	-84K	-158.26M	-214.62M
Shareholders Equity	138.99M	155.81M	170.68M	183.29M	190.02M	91.06M	97.88M	-198.41M	-192.7M	-186.95M	56.37M	-140.58M
Total Investments	n/a	82.82M	92.94M	92.53M	16.93M	19.76M	n/a	n/a	12.92M	32.19M	113.46M	n/a